Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2000
10/17/2000CA2177357C Pna-dna-pna chimeric macromolecules
10/17/2000CA2104899C Antibodies to plasmodium falciparum
10/12/2000WO2000059932A1 Influenza virus hemagglutinin-binding peptides
10/12/2000WO2000059527A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
10/12/2000WO2000020587A3 Cancer associated antigens and uses therefor
10/12/2000WO2000018440A9 Somatostatin receptor radioligand with increased uptake
10/12/2000WO2000005250A9 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
10/12/2000CA2368387A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
10/12/2000CA2365575A1 Influenza virus hemagglutinin-binding peptides
10/11/2000EP1042365A1 Compounds and methods for modulating occludin related tissue permeability
10/11/2000EP0937101B1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them
10/11/2000CN1269804A CTL epitopes from EBV
10/11/2000CN1057306C New polypeptide compound and process for preparation thereof
10/10/2000US6130314 Peptide which is immunoreactive to antibodies to lymphadenopathy virus and human t-cell lymphotropic virus; for detection of exposure to virus and screening blood products
10/10/2000US6130204 Peptides
10/10/2000CA2195625C Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same
10/10/2000CA2106762C Bradykinin antagonist peptides
10/05/2000WO2000058363A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
10/05/2000WO2000058361A1 Melanocortin receptor ligands
10/05/2000WO2000058354A1 Peptides useful in treating multiple sclerosis and a pharmaceutical composition comprising the same
10/05/2000WO2000058349A1 Peptide vaccine for canine allergy
10/05/2000WO2000058342A1 Process for partitioning of proteins
10/05/2000WO2000057896A1 Modulators of polysaccharides and uses thereof
10/05/2000WO2000032228A3 Peptide-based vaccine for influenza
10/05/2000WO2000029427A3 Antennapedia homeodomain helix 3 derived translocation vectors
10/05/2000WO2000027880A3 Rantes-derived peptides with anti-hiv activity
10/05/2000WO2000011179A9 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM)
10/05/2000WO2000005249A3 Synthetic peptides and methods of use for autoimmune disease therapies
10/05/2000CA2367901A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
10/05/2000CA2367826A1 Process for partitioning of proteins
10/05/2000CA2366604A1 Modulators of polysaccharides and uses thereof
10/05/2000CA2329152A1 Peptide vaccine for canine allergy
10/04/2000EP1040122A1 Protein binding polypeptides
10/04/2000EP1040121A1 Novel method for preparing cylosporin derivatives
10/04/2000EP1040120A1 Antifungal and antibacterial peptides
10/04/2000EP1039934A1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
10/04/2000EP1039923A1 Gamma-conopeptides
10/04/2000CN1057118C Recombinant C140 receptor
10/04/2000CN1057095C Novel peptides, prepn. and use thereof
10/03/2000US6127519 Calcitonin derivatives
10/03/2000US6127391 Compounds with growth hormone releasing properties
10/03/2000US6127341 Aminomethyl-n-(1-((2-(2-thienyl)-1-(1-carbamoyl-5 -aminopentylcarbamoyl)ethyl)-n-methylcarbamoyl)-2-(2 -napthyl)ethyl)benzamide, for example; administering to stimulate growth, milk or wool production in animals
10/03/2000US6127339 Peptide for binding thereto a low density lipoprotein
10/03/2000US6127338 Three peptides of given amino acid sequences with antihyperglycemic activity; extracts of the fruit momordica charantia
10/03/2000US6127335 Cyclic adhesion inhibitors
10/03/2000US6127333 Conjugates useful in the treatment of prostate cancer
10/03/2000US6127170 Multifunctional complexes for gene transfer into cells comprising a nucleic acid bound to a polyamine and having a endosome disruption agent
10/03/2000US6127150 Vector for the efficient expression and isolation of heterologous proteins
10/03/2000US6127139 Method for assaying proteolytic enzymes using fluorescence-quenched substrates
10/03/2000US6127119 Detecting nucleotide sequences with receptivity to blood vessels; incubating mixture of nucleotide sequences with blood vessels, partitioning sequences with amplified affinity, amplifying nucleotide sequences
10/03/2000US6126916 Radiometal-binding peptide analogues
10/03/2000CA2079171C Cyclohexapeptidyl propanolamine compounds
10/03/2000CA2000342C Novel peptidase inhibitors
10/03/2000CA1341106C Conformationally stabilized cell adhesion peptides
09/2000
09/28/2000WO2000056761A1 Peptides blocking response to chemical substances or thermal stimuli or nociceptor inflammation mediators and compositions containing said peptides
09/28/2000WO2000056353A2 A uro-genital condition treatment system
09/28/2000WO2000056345A2 Methods for limiting scar and adhesion formation
09/28/2000WO2000056144A1 Human sperm surface antigen
09/28/2000WO2000042973A3 Homing pro-apoptotic conjugates and methods of using same
09/28/2000DE19911771A1 Neue LHRH-Antagonisten mit verbesserten Löslichkeitseigenschaften New LHRH antagonists with improved solubility
09/28/2000CA2367118A1 A uro-genital condition treatment system
09/27/2000EP1037906A1 Cyclopeptide derivatives with integrin inhibitor properties
09/27/2000EP1037651A1 Small peptides and methods for treatment of asthma and inflammation
09/27/2000EP0677116B1 A process for producing immunosuppressives and a novel microbial species to be employed therein
09/27/2000CN1056851C Cyclic adhesion inhibitors
09/26/2000US6124431 Peptide derivatives
09/26/2000US6124430 Amino acid squences useful as a reagent in an immunoassay for measuring and detection of heart hormone protein
09/26/2000US6124429 Fibrous protein to be used as biocompatible polymer for surgical sutures, artificial blood vessels and artificial tissues
09/26/2000US6124261 Non-aqueous polar aprotic peptide formulations
09/26/2000US6124102 Methods for determining receptor-ligand binding using probe arrays
09/26/2000US6124101 Diagnosis of thrombosis in a mammals; incubating a sample of fluid with an antibody that preferentially binds a cleaved activation peptide, counting antibody bound cleaved activation peptides, compare to control
09/26/2000CA2200069C Anti-fungal peptides
09/21/2000WO2000055372A1 Methods and apparatus for detecting nucleic acid polymorphisms
09/21/2000WO2000055305A1 Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides
09/21/2000WO2000055190A1 Novel lhrh antagonists with improved solubility characteristics
09/21/2000WO2000055186A1 Antibiotic wap-2607b, process for producing the same and antibacterial agents
09/21/2000WO2000055149A1 Dimeric compounds and as inhibitors of neuraminidase
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/20/2000EP1036798A1 Peptides having anti-cell adhesion activity
09/20/2000EP1036093A1 Conjugates useful in the treatment of prostate cancer
09/20/2000EP1036091A1 5t4 tumour-associated antigen for use in tumour immunotherapy
09/20/2000EP1036090A1 Echinocandin derivatives, preparation method and application as anti-fungal agents
09/20/2000EP1036089A1 Wound healing compositions
09/20/2000EP1035865A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
09/20/2000EP1035861A1 Threonine-containing protegrins
09/20/2000EP0832119B1 Anti-fungal and anti-bacterial histatin-based peptides
09/20/2000EP0600992B1 Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
09/20/2000EP0495836B2 Dye transfer inhibition
09/20/2000CN1056615C Difluoro pentapeptide deriv. antiinflammatory agent
09/19/2000US6121426 Fibrin binding domain polypeptides and uses and methods of producing same
09/19/2000US6121417 Inhibitors of retroviral protease
09/19/2000US6121416 Peptide which prevents the binding of somatomedins and their binding proteins; for the treatment of hyperglycemic, obesity, nervous system, cardiovascular, kidney, immunological and metabolic disorders
09/19/2000US6121238 Peptides and compounds that bind to a receptor
09/19/2000US6120765 Purified peptide
09/19/2000CA2266298A1 Synthesis and evaluation of two technetium-99m-labeled peptidic 2-nitroimidazoles for imaging hypoxia
09/19/2000CA2266233A1 A novel n-formylpeptide analogue: a potential inflammation and infection imaging agent
09/19/2000CA2106768C Bradykinin type peptides
09/19/2000CA2079187C Cyclohexapeptidyl bisamine compounds
09/19/2000CA2053242C Protease inhibitor